Pharmascience Looks Back At First Year Of New CDMO Unit
Pharmascience’s John Foy Discusses The Company’s Latest Efforts And Plans
Almost a year since the establishment of an expanded CDMO business unit, Canada’s Pharmascience has doubled down on its plans to expand its presence through the pharmaceutical industry.
